Neuropsychiatric aid in children born to patients with rheumatic diseases

M Bomba1, J Galli, R Nacinovich

  • 1Department of Child and Adolescent Neuropsychiatry, University of Medicine, Brescia, Italy. monica.bomba@gmail.com

Insights

Mothers with rheumatic diseases (RD) may face challenges in bonding with their babies due to emotional distress. Early neuropsychiatric support can improve maternal-foetal attachment and child development outcomes.

Area of Science:

  • Reproductive medicine
  • Developmental psychology
  • Rheumatology

Background:

  • Chronic rheumatic diseases (RD) can negatively impact maternal quality of life and relationships.
  • Maternal distress affects mother-infant bonding, potentially leading to developmental issues in children.
  • Psychological challenges in pregnancy and parenthood are significant for women with RD.

Purpose of the Study:

  • To review the psychological aspects of pregnancy and parenthood in women with RD.
  • To explore the impact of maternal RD on child development.
  • To highlight the importance of multidisciplinary care for affected families.

Main Methods:

  • Literature review on psychological aspects of pregnancy and parenthood in women with rheumatic diseases.
  • Analysis of case experiences and existing research.
  • Focus on maternal-foetal attachment, infant development, and parental stress.

Main Results:

  • Maternal distress in RD can impair mother-baby interaction and attachment.
  • Ineffective infant holding may lead to stress vulnerability and psychosomatic issues in offspring.
  • Psychological support is crucial for managing pregnancy and parenthood in women with RD.

Conclusions:

  • A collaborative, multidisciplinary team approach is essential for supporting pregnant women with RD.
  • Neuropsychiatric interventions can aid patients and partners, preventing psychopathologic traits.
  • Integrated care improves the overall quality of life for the family unit.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...